Your session is about to expire
← Back to Search
Body Position for Aspiration in Infants
N/A
Waitlist Available
Led By Sara Burnham
Research Sponsored by Connecticut Children's Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up number of sucks, swallows, and breaths will be counted for each swallowing trial for each infant for the entirety of the study, roughly 1 year.
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare how safe it is for babies to swallow in an upright vs. side-lying position to protect their airways.
Who is the study for?
This trial is for infants aged 38-56 weeks post-menstrual who have been referred for a Modified Barium Swallow (MBS) study due to suspected oropharyngeal dysphagia. Only those confirmed with pharyngeal dysphagia will be included in the final analysis. Infants must be medically stable and able to maintain side-lying or upright positions for at least 3 minutes.
What is being tested?
The study tests whether feeding infants in a side-lying position, as opposed to the typical upright position, affects their risk of aspiration and overall swallow function. It involves an instrumental assessment using MBS to compare airway protection between these two positions.
What are the potential side effects?
Since this trial involves standard feeding positions and diagnostic imaging, there are minimal expected side effects; however, discomfort from positioning or reactions related to the barium used in MBS may occur.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ number of sucks, swallows, and breaths will be counted for each swallowing trial for each infant for the entirety of the study, roughly 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~number of sucks, swallows, and breaths will be counted for each swallowing trial for each infant for the entirety of the study, roughly 1 year.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Airway invasion outcome
Secondary study objectives
Suck-swallow-breathe (SSwB) coordination outcome
Swallow initiation outcome
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Sidelying, then UprightActive Control2 Interventions
Positioning in sidelying on radiology table for assessment, then will be positioned upright in tumbleform. Same bottle and liquid viscosities will be assessed in both positions.
Group II: Upright, then SidelyingActive Control2 Interventions
Positioned upright in tumbleform, then will be positioned sidelying on radiology table for assessment. Same bottle and liquid viscosities will be assessed in both positions.
Find a Location
Who is running the clinical trial?
Connecticut Children's Medical CenterLead Sponsor
73 Previous Clinical Trials
26,584 Total Patients Enrolled
Sara BurnhamPrincipal InvestigatorConnecticut Children's Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My infant cannot stay upright or on their side for 3 minutes.My infant does not meet the specified inclusion criteria.My infant is between 38 to 56 weeks post-menstrual age.My infant has a swallowing disorder confirmed by a special X-ray test.
Research Study Groups:
This trial has the following groups:- Group 1: Sidelying, then Upright
- Group 2: Upright, then Sidelying
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.